Evidence map›Paper›PMID 26569092›Full record

ArticleBone marrow transplantation2016

A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).

L Platon, L Amigues, P Ceballos, N Fegueux, D Daubin, N Besnard, R Larcher, L Landreau, C Agostini, S Machado and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

L PlatonDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
L AmiguesDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
P CeballosDepartment of Hematology, Lapeyronie University Hospital, Montpellier, France.
N FegueuxDepartment of Hematology, Lapeyronie University Hospital, Montpellier, France.
D DaubinDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
N BesnardDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
R LarcherDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
L LandreauDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
C AgostiniDepartment of Statistics, Lapeyronie University Hospital, Montpellier, France.
S MachadoDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
O JonquetDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
K KloucheDepartment of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
Centre Hospitalier Universitaire de Montpellier · FRHôpital Lapeyronie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiology and prognosis of complications related to allogeneic hematopoietic stem cell transplant (HSCT) recipients requiring admission to intensive care unit (ICU) have not been reassessed precisely in the past few years. We performed a retrospective single-center study on 318 consecutive HSCT patients (2009-2013), analyzing outcome and factors prognostic of ICU admission. Among these patients, 73 were admitted to the ICU. In all, 32 patients (40.3%) died in ICU, 46 at hospital discharge (63%) and 61 (83.6%) 1 year later. Survivors had a significantly lower sequential organ failure assessment (SOFA) score, serum lactate and bilirubin upon ICU admission. Catecholamine support, mechanical ventilation (MV) and/or renal replacement therapy during ICU stay, a delayed organ support and an active graft versus host disease (GvHD) significantly worsen the outcome. By multivariate analysis, the worsening of SOFA score from days 1 to 3, the need for MV and the occurrence of an active GvHD were predictive of mortality. In conclusion, the incidence of HSCT-related complications requiring an admission to an ICU was at 22%, with an ICU mortality rate of 44%, and 84% 1 year later. A degradation of SOFA score at day 3 of ICU, need of MV and occurrence of an active GvHD are main predictive factors of mortality.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationIntensive Care UnitsAdultAllograftsDisease-Free SurvivalFemaleFollow-Up StudiesHumansMaleMiddle AgedRisk FactorsSurvival Rate

Identifiers

PMID26569092
OpenAlexW2177928242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.